FDAnews
www.fdanews.com/articles/180353-fda-awards-otc-clearances-for-drug-free-musculoskeletal-pain-therapy

FDA Awards OTC Clearances for Drug-free Musculoskeletal Pain Therapy

February 6, 2017

Frederick, Maryland–based, BioElectronics gained over-the-counter use FDA market clearance for ActiPatch for the adjunctive treatment of musculoskeletal pain related to plantar fasciitis of the heel and osteoarthritis of the knee.

The device uses low power pulse electromagnetic fields to regulate electrical activity in the nervous system. — Cynthia Jessup

View today's stories